Eurepa-V 0.5/0.3 Tablet
Prescription Required
Introduction of Eurepa-V Tablet
Eurepa-V 0.5/0.3 Tablet is a combination of two medicines used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Eurepa-V 0.5/0.3 Tablet is a combination of two antidiabetic medicines
Eurepa-V 0.5/0.3 Tablet is a combination of two antidiabetic medicines
Uses of Eurepa-V Tablet
Benefits of Eurepa-V Tablet
In Treatment of Type 2 diabetes mellitus
Eurepa-V 0.5/0.3 Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Eurepa-V 0.5/0.3 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Eurepa-V 0.5/0.3 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Eurepa-V Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Eurepa-V
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
- Upper respiratory tract infection
- Headache
How to use Eurepa-V Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Eurepa-V 0.5/0.3 Tablet is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Eurepa-V 0.5/0.3 Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Eurepa-V 0.5/0.3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Eurepa-V 0.5/0.3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
Eurepa-V 0.5/0.3 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Eurepa-V 0.5/0.3 Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Eurepa-V 0.5/0.3 Tablet should be used with caution in patients with liver disease. Dose adjustment of Eurepa-V 0.5/0.3 Tablet may be needed. Please consult your doctor.
What if you forget to take Eurepa-V Tablet?
If you miss a dose of Eurepa-V 0.5/0.3 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Eurepa-V 0.5/0.3 Tablet
βΉ14.07/Tablet
Vogli-Rapid 0.3/0.5 Tablet
Medley Pharmaceuticals
βΉ11.85/tablet
16% cheaper
Volga R 0.5mg/0.3mg Tablet
Ajanta Pharma Ltd
βΉ10.75/tablet
24% cheaper
Trubogli XL 0.5mg/0.3mg Tablet
AAR ESS Remedies Pvt Ltd
βΉ24.5/tablet
74% costlier
Voglinorm-R Tablet
Micro Labs Ltd
βΉ12.8/tablet
9% cheaper
Ppg-R 0.5 Tablet
Abbott Healthcare Private Limited
βΉ11.4/tablet
19% cheaper
Quick tips
Eurepa-V Tablet
- Eurepa-V 0.5/0.3 Tablet is a combination medicine that can control blood sugar better than either medicine alone.
- Exercise, eat a healthy diet, and take your other diabetes medicines along with Eurepa-V 0.5/0.3 Tablet.
- Take it around 15 minutes before a main meal.
- It can cause hypoglycemia (low blood sugar level) with other antidiabetic medicines, alcohol or if you delay a meal. Check your blood sugar regularly.
- Always carry some sugary food to manage hypoglycemia symptoms (cold sweats, pale skin, tremors, and anxiety).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Repaglinide. Gatwick, West Sussex: Novo Nordisk Limited; 2001 [revised May 2016]. [Accessed 29 Apr. 2019] (online) Available from:
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 12 Mar. 2019] (online) Available from:
- Repaglinide and Voglibose Tablets [Prescribing Information]. Sikkim, India: Torrent Pharmaceuticals Ltd.; 2019. [Accessed 28 Oct. 2021] (online) Available from:
- Repaglinide and Voglibose Tablets [Prescribing Information]. Sikkim, India: Torrent Pharmaceuticals Ltd.; 2021. [Accessed 28 October 2021] (online) Available from:
Marketer details
Name: Torrent Pharmaceuticals Ltd
Address: Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
100 people bought this recentlyMRP
βΉ140.7
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT